Calafiore resigned as NuVasive’s chief commercial officer last month. He also served as an EVP at the orthopedic device company before his departure.
Before serving as EVP and CCO, Calafiore oversaw NuVasive’s product marketing and commercial functions. He also held responsibility for the company’s business units, including specialized orthopedics and clinical services. Calafiore now brings more than 20 years of experience in the orthopedic field to the corner office at LimaCorporate.
“I am honored to take on this role as CEO of LimaCorporate. Thanks to our internal talent, know-how, and industry-leading R&D capabilities, I will continue to focus on positioning the company as a global leader in advanced orthopedic solutions,” Calafiore said in a news release. “I look forwards to working closely with all the employees and the leadership team to continue to serve our surgeons and patients around the globe, as we transform orthopedics, advance patient care, and most importantly, restore the emotion of motion in all of our patients.
Interim CEO to become chief commercial officer
Emmanuel Bonhomme led LimaCorporate for the past five months as interim CEO. He will take the newly created role of chief commercial officer at the company.
“It has been a pleasure and an honor to lead LimaCorporate during the last five months as interim CEO and I am very excited to carry on serving our surgeons around the world in my new role,” Bonhomme said. “I welcome Massimo as our new CEO and I am committed to supporting him and the company to continue to enhance LimaCorporate’s position in the industry, offering the best and most advanced solutions for our surgeons and patients.”
LimaCorporate develops reconstructive and custom-made orthopedic solutions. It also offers the ProMade 3D-printed custom service, which incorporates design and manufacturing in its unique PoC Center in New York.
“We strongly believe that Massimo is the right person to lead this new phase of our business,” said LimaCorporate advisory board chair Lars Rasmussen. “He brings extensive industry experience, excellent strategic and leadership skills and a track record of values-based leadership focused on improving patients’ lives. I would like to thank Emmanuel Bonhomme for his dedication as interim CEO and congratulate him on his new role as chief commercial officer.”